Jena D French

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. doi request reprint Revisiting immune-based therapies for aggressive follicular cell-derived thyroid cancers
    Jena D French
    Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado, Aurora, CO 80045, USA
    Thyroid 23:529-42. 2013
  2. pmc Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer
    Jena D French
    University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 97:E934-43. 2012
  3. pmc Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer
    Jena D French
    Department of Medicine, University of Colorado Denver, 12801 East 17th Avenue, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 95:2325-33. 2010
  4. pmc Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer
    Rebecca E Schweppe
    Division of Endocrinology, Diabetes, and Metabolism, University of Colorado Denver, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 94:2199-203. 2009

Detail Information

Publications4

  1. doi request reprint Revisiting immune-based therapies for aggressive follicular cell-derived thyroid cancers
    Jena D French
    Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado, Aurora, CO 80045, USA
    Thyroid 23:529-42. 2013
    ..Concurrent inflammation has long been associated with follicular cell-derived thyroid cancer (FDTC). In the last decade, much research has focused on characterizing the tumor-associated immune response in patients with FDTC...
  2. pmc Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer
    Jena D French
    University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 97:E934-43. 2012
    ..Novel prognostic markers may be helpful in guiding a therapeutic approach. Our previous studies revealed that immune suppression is evident in PTC and associated with more severe disease...
  3. pmc Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer
    Jena D French
    Department of Medicine, University of Colorado Denver, 12801 East 17th Avenue, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 95:2325-33. 2010
    ..Immune-based therapies are under investigation to treat many types of cancer. The role of the immune system in PTC is poorly understood...
  4. pmc Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer
    Rebecca E Schweppe
    Division of Endocrinology, Diabetes, and Metabolism, University of Colorado Denver, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 94:2199-203. 2009
    ..The role of the Src-FAK complex has not been characterized in papillary and anaplastic thyroid cancer (PTC and ATC)...